Bioventus

BVS

12.4505.51% ( +0.650 )

Closed: Jul 27, 16:00:00 (EDT)

Q1 FY2026 Earnings

Financial report interval: 2025.12.31 - 2026.03.31

Preview: Bioventus(BVS) predict that the Revenue is 132.09 M (+6.63%), Beat estimate;the EBIT is 20.28 M (+14.57%), Beat estimate;the EPS is 0.04 (+200%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

0.13B6.63%

0.13B4.86%

+0.00B1.77%

EBITExceed expectations

0.02B14.57%

0.02B11.76%

+0.00B2.81%

EPSExceed expectations

0.04200.00%

-0.01465.00%

+0.0540135.00%

Revenue

ActualEstimateUnit: USD

EBIT

ActualEstimateUnit: USD

Net income

ActualEstimateUnit: USD

EPS

ActualEstimateUnit: USD